|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | |||||||||
| Restricted cash | |||||||||
| Accounts receivable | |||||||||
| Inventories, net | |||||||||
| Prepaid expenses | |||||||||
| Total current assets | |||||||||
| Property and equipment, net | |||||||||
| Goodwill | |||||||||
| Patents, net | |||||||||
| Other assets | |||||||||
| Total assets | |||||||||
| Liabilities and Stockholders' Equity | |||||||||
| Current liabilities: | |||||||||
| Accounts payable | |||||||||
| Accrued liabilities | |||||||||
| Warrant derivative liability | |||||||||
| Deferred revenue - current portion | |||||||||
| Total current liabilities | |||||||||
| Deferred revenue | |||||||||
| Total liabilities | |||||||||
| Commitments and contingencies (Note 11) | |||||||||
| Stockholders' equity: | |||||||||
| Preferred stock | |||||||||
| Series A Preferred Stock | |||||||||
| Series B Preferred Stock | |||||||||
| Common stock, $0.0001 par value: 100,000,000 shares authorized; 38,823,487 shares issued and outstanding at September 30, 2013 and 37,041,170 shares issued and outstanding at December 31, 2012 | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| Total stockholders' equity | |||||||||
| Total liabilities and stockholders' equity |
Loading...
